Search Share Prices
AZN News - FTSE 100 dives again but supermarkets defy the trend
The FTSE 100 is down 195 points at 6,510 but even on a day of widescale carnage, there are some bright spots. Pharma stocks are also regarded as defensive investments, which may account for why ...
Shore Capital Reiterates “Buy” Rating for AstraZeneca (LON:AZN)
AstraZeneca (LON:AZN)‘s stock had its “buy” rating reaffirmed by research analysts at Shore Capital in a note issued to investors on Friday, ThisIsMoney.Co.Uk reports. Several other equities research ...
AstraZeneca (LON:AZN) Given “Buy” Rating at Liberum Capital
AstraZeneca (LON:AZN)‘s stock had its “buy” rating reissued by equities researchers at Liberum Capital in a research note issued on Friday, ThisIsMoney.Co.Uk reports. A number of other equities ...
AstraZeneca posts negative results for late-stage bladder cancer treatment
AstraZeneca PLC (LON:AZN) has announced that an already approved treatment was not effective in patients with late-stage bladder cancer. The FTSE 100-listed pharma company was in phase III of trials ...
Broker Forecast - UBS issues a broker note on AstraZeneca PLC
StockMarketWire.com - UBS today reaffirms its sell investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 6000p (from 5800p).